Autoantibody assays may have significant differences due to the heterogeneity of autoantibodies, including epitope specificity, isotype, and affinity/avidity. This makes it challenging for clinical ...
In the scurry to track, isolate and otherwise beat back the global coronavirus pandemic, testing people for traces of SARS-CoV-2, the virus that causes COVID-19, is a high priority. But a different ...
Americans may soon be able to learn if they've ever been infected with COVID-19 with a prick of their finger and a smartphone — and without having to leave their homes. A Los Angeles digital ...
In January 2020, the Food and Drug Administration (FDA) began considering the U.S. response to Covid-19. On February 4, after the declaration of a public health emergency, we began authorizing tests ...
A Garden Grove physician is likely one of the first practitioners in the U.S. to begin offering a rapid coronavirus screening test popular in Asia that can provide results within 10 minutes through a ...
Individuals who were already pregnant at the beginning of the COVID-19 pandemic had a 50 percent lower exposure to SARS-CoV-2 compared with those who became pregnant after the pandemic began and the ...
Against a backdrop of dynamic federal regulations and a quickly expanding commercial landscape, labs are facing unusual obstacles in validating serology testing for COVID-19. Issues with test accuracy ...
The Families First Coronavirus Response Act (FFCRA) was passed by Congress on March 18 and mandated that Medicare, Medicaid, and private insurance plans cover COVID-19 testing and administration costs ...